Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium.
about
Clinical validity and utility of genetic risk scores in prostate cancerA comparison of genetic risk score with family history for estimating prostate cancer riskMultiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networksNovel bone endocrine networks integrating mineral and energy metabolismGenome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.Evaluating genetic risk for prostate cancer among Japanese and Latinos.Prostate cancer risk-associated genetic markers and their potential clinical utilityAssociation of a common variant at 10q26 and benign prostatic hyperplasia aggressiveness in han chinese descent.A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs.Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.Variants at IRX4 as prostate cancer expression quantitative trait loci.A genome-wide association study of prostate cancer in West African men.Genome-wide association studies on prostate cancer: the end or the beginning?The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function.Insights into Chinese prostate cancer with RNA-seq.Genetic variants in 2q31 and 5p15 are associated with aggressive benign prostatic hyperplasia in a Chinese population.A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population.TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese.Validation of the novel susceptibility loci for prostate cancer in a Chinese population.
P2860
Q26746219-880F5539-129E-4AF3-90CE-AFAAED70C15BQ26752649-F2674C05-E935-4199-A57C-F246DEEDD99DQ26862997-6CEABB37-A447-4EE2-AA6F-7D4693E24404Q33572134-7730CE8C-2188-4732-A892-3A82E5360A33Q33977740-5BECE3CC-5F2B-4A81-AA96-BEB3BD02A68AQ36100579-FE35700F-5FD0-4034-A424-394942823A7FQ36250030-0AC21C67-140E-4C2B-AC0C-9C08D69AF961Q36331604-FFCF07F0-E4AE-4BE3-814B-B2E8AD877603Q36388749-C197826A-974E-4C66-9EBE-36F7759DF5A1Q37085446-91A40934-5D76-468A-A5B2-6E03FAC541F9Q37105061-026BFF5C-25D9-4B24-96D2-953540DC3255Q37127412-53C9D29A-6FCC-4F38-BDE9-96A164115247Q37541290-95969378-88B2-4657-8BFE-9B0168941EE7Q37592171-9804F5F2-851C-4DA3-8E77-E134AC76E5CDQ37636770-118C96F1-44D4-4EA8-88A0-2E4F7B10C7EBQ37705188-AB07559E-1F4C-485C-8F7A-F7FC9C0473D0Q38132063-B204BC69-B285-44FF-B59D-7A608EDA8F37Q38137171-C51736A5-1F67-4E64-8EB6-0884BF7EB781Q42146716-C218FBFA-A78F-458E-8059-4EA2A646DB4BQ44002659-3621344E-A578-4A47-92C6-B994119C854DQ46000370-2941EF41-777D-4ECE-B1FC-FB89E6AAA1A5Q47671913-BB166042-BF31-4C80-9B70-0F14F4F1167CQ47756925-086121FC-00AF-4CF7-8CE9-B81FDC45FCC0Q49639446-67D9F945-69EF-4B90-838C-B86778B2677C
P2860
Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Replication and cumulative eff ...... dy in the ChinaPCa consortium.
@ast
Replication and cumulative eff ...... dy in the ChinaPCa consortium.
@en
type
label
Replication and cumulative eff ...... dy in the ChinaPCa consortium.
@ast
Replication and cumulative eff ...... dy in the ChinaPCa consortium.
@en
prefLabel
Replication and cumulative eff ...... dy in the ChinaPCa consortium.
@ast
Replication and cumulative eff ...... dy in the ChinaPCa consortium.
@en
P2093
P2860
P356
P1433
P1476
Replication and cumulative eff ...... dy in the ChinaPCa consortium.
@en
P2093
Ann W Hsing
Changjun Yin
Guangfu Jin
Guozeng Wang
Haowen Jiang
Hongyan Chen
Jiangyu Rao
P2860
P304
P356
10.1093/CARCIN/BGR279
P407
P577
2011-11-23T00:00:00Z